Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$80,128,453
in 11 filings, $80.1M under 10b5-1 plans

Net −$80,128,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
  2. Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
  3. ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
  4. Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
  5. Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-10 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +5,000 40,895
2022-01-10 Clague Laura Chief Financial Officer Grant or award +7,500 38,816
2022-01-05 Dube Eric M Chief Executive Officer Sale −10,361 $29.84 $309K 141,722
2022-01-05 Dube Eric M Chief Executive Officer Sale −2,139 $30.48 $65K 139,583
2022-01-04 Dube Eric M Chief Executive Officer Sale −4,832 $30.43 $147K 152,083
2022-01-01 Inrig Jula Chief Medical Officer Grant or award +20,000 20,000
2022-01-01 Inrig Jula Chief Medical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-11-16 ASELAGE STEVE Director Sale −31,800 $29.39 $935K 149,494
2021-11-05 ASELAGE STEVE Director Option exercise +10,000 $16.23 $162K 171,794
2021-11-05 ASELAGE STEVE Director Sale −10,000 $26.23 $262K 161,794
2021-11-05 ASELAGE STEVE Director Option exercise · Employee stock option (right to buy) −10,000 70,000
2021-11-02 ASELAGE STEVE Director Sale −3,500 $30.00 $105K 19,500
2021-11-01 ASELAGE STEVE Director Sale −5,000 $29.48 $147K 23,000
2021-10-07 ASELAGE STEVE Director Option exercise +60,000 $16.23 $974K 249,794
2021-10-07 ASELAGE STEVE Director Sale −28,000 $26.23 $734K 221,794
2021-10-07 ASELAGE STEVE Director Sale −32,000 $26.26 $840K 189,794
2021-10-07 ASELAGE STEVE Director Option exercise · Employee stock option (right to buy) −60,000 80,000
2021-10-04 Heerma Peter Chief Commercial Officer Sale −3,058 $24.77 $76K 60,457
2021-09-14 Brinkley Ruth Williams Director Grant or award +5,250 5,250
2021-09-14 Brinkley Ruth Williams Director Grant or award · Stock Option (Right to Buy) +15,750 15,750

Page 33 of 51 · 1,020 trades